H.U. Group Holdings, Inc. (TYO:4544)
3,670.00
+134.00 (3.79%)
Aug 12, 2026, 3:15 PM JST
H.U. Group Holdings Revenue
In the fiscal year ending March 31, 2026, H.U. Group Holdings had annual revenue of 247.36B JPY with 1.78% growth. H.U. Group Holdings had revenue of 60.63B in the quarter ending March 31, 2026, a decrease of -0.57%.
Revenue
247.36B
Revenue Growth
+1.78%
P/S Ratio
0.79
Revenue / Employee
47.97M
Employees
5,157
Market Cap
194.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 247.36B | 4.34B | 1.78% |
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.62T |
| Otsuka Holdings | 2.62T |
| Chugai Pharmaceutical | 1.34T |
| HOYA Corporation | 983.64B |
| Ain Holdings | 647.83B |
| Create SD Holdings | 497.13B |
| Towa Pharmaceutical | 279.94B |
| Sawai Group Holdings | 201.68B |